Sign in
4

Changes in Ownership

PRECISION BIOSCIENCES INC Filed Acc 0001209191-21-012745

President and CEO sold 9,705 shares at $12.23 ($118,692)

  • President and CEO acquired 21,514 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
KANE MATTHEW R. President and CEO 2021-02-18 Option exercise +21,514 $0.04 $861 1,899,151 D: show line 1 in the form
KANE MATTHEW R. President and CEO 2021-02-18 Sale −9,705 $12.23 $118,692 1,889,446 D: show line 2 in the form
Open-market sales · 9,705 sh · avg $12.23 · $118,692

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
KANE MATTHEW R. President and CEO 2021-02-18 Option exercise · Employee Stock Option (Right to Buy) −21,514 193,626 D: show line 3 in the form
Loading xslF345X03/doc4.xml…